Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations

被引:2
作者
Langabeer, Stephen E. [1 ]
Haslam, Karl [1 ]
Linders, Jennifer [2 ]
Percy, Melanie J. [3 ]
Conneally, Eibhlin [4 ]
Hayat, Amjad [5 ]
Hennessy, Brian [6 ]
Leahy, Maeve [7 ]
Murphy, Karen [8 ]
Murray, Margaret [5 ]
Ainle, Fionnuala Ni [9 ]
Thornton, Patrick [10 ]
Sargent, Jeremy [2 ]
机构
[1] St James Hosp, Canc Mol Diagnost, Cent Pathol Lab, Dublin 8, Ireland
[2] Our Lady Lourdes Hosp, Dept Haematol, Drogheda, Ireland
[3] Belfast City Hosp, Dept Haematol, Belfast BT9 7AD, Antrim, North Ireland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
[5] Galway Univ Hosp, Dept Haematol, Galway, Ireland
[6] Waterford Reg Hosp, Dept Haematol, Waterford, Ireland
[7] Univ Hosp Limerick, Dept Haematol, Limerick, Ireland
[8] St Vincents Univ Hosp, Dept Haematol, Dublin 4, Ireland
[9] Mater Misericordiae Univ Hosp, Dept Haematol, Dublin, Ireland
[10] Beaumont Hosp, Dept Haematol, Dublin 9, Ireland
关键词
Familial myeloproliferative neoplasms; JAK2; CALR; MPL; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC ERYTHROCYTOSIS; CONFERS SUSCEPTIBILITY; PRIMARY MYELOFIBROSIS; POLYCYTHEMIA-VERA; EXON-12; MUTATIONS; GGCC HAPLOTYPE; DISORDERS; COMPLICATIONS; THERAPY;
D O I
10.1007/s10689-014-9743-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The myeloproliferative neoplasms (MPN) are clonal, hematological malignancies that include polycythemia vera, essential thrombocythemia and primary myelofibrosis. While most cases of MPN are sporadic in nature, a familial pattern of inheritance is well recognised. The phenotype and status of the commonly acquired JAK2 V617F, CALR exon 9 and MPL W515L/K mutations in affected individuals from a consecutive series of ten familial MPN (FMPN) kindred are described. Affected individuals display the classical MPN phenotypes together with one kindred identified suggestive of hereditary thrombocytosis. In affected patients the JAK2 V617F mutation is the most commonly acquired followed by CALR exon nine mutations with no MPL W515L/K mutations detected. The JAK2 V617F and CALR exon 9 mutations appear to occur at approximately the same frequency in FMPN as in the sporadic forms of these diseases. The familial nature of MPN may often be overlooked and accordingly more common than previously considered. Characterisation of these FMPN kindred may allow for the investigation of molecular events that contribute to this inheritance.
引用
收藏
页码:659 / 663
页数:5
相关论文
共 35 条
[1]   Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms [J].
Anderson, Lesley A. ;
Duncombe, Andrew S. ;
Hughes, Maria ;
Mills, Moyra E. ;
Wilson, Jessica C. ;
McMullin, Mary F. .
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) :175-182
[2]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[3]   Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases [J].
Bento, Celeste ;
Percy, Melanie J. ;
Gardie, Betty ;
Magalhaes Maia, Tabita ;
van Wijk, Richard ;
Perrotta, Silverio ;
Della Ragione, Fulvio ;
Almeida, Helena ;
Rossi, Cedric ;
Girodon, Francois ;
Astrom, Maria ;
Neumann, Drorit ;
Schnittger, Susanne ;
Landin, Britta ;
Minkov, Milen ;
Randi, Maria Luigia ;
Richard, Stephane ;
Casadevall, Nicole ;
Vainchenker, William ;
Rives, Susana ;
Hermouet, Sylvie ;
Ribeiro, M. Leticia ;
McMullin, Mary Frances ;
Cario, Holger .
HUMAN MUTATION, 2014, 35 (01) :15-26
[4]   Identification of MPL W515L/K Mutations in Patients with Primary Myelofibrosis and Essential Thrombocythaemia by Allele-Specific Polymerase Chain Reaction [J].
Daly, Sarah ;
Conneally, Eibhlin ;
Langabeer, Stephen E. .
ACTA HAEMATOLOGICA, 2009, 121 (04) :221-222
[5]   A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis [J].
Etheridge, S. Leah ;
Cosgrove, Megan E. ;
Sangkhae, Veena ;
Corbo, Lana M. ;
Roh, Michelle E. ;
Seeliger, Markus A. ;
Chan, Edward L. ;
Hitchcock, Ian S. .
BLOOD, 2014, 123 (07) :1059-1068
[6]   Laboratory Practice Guidelines for Detecting and Reporting JAK2 and MPL Mutations in Myeloproliferative Neoplasms A Report of the Association for Molecular Pathology [J].
Gong, Jerald Z. ;
Cook, James R. ;
Greiner, Timothy C. ;
Hedvat, Cyrus ;
Hill, Charles E. ;
Lim, Megan S. ;
Longtine, Janina A. ;
Sabath, Daniel ;
Wang, Y. Lynn .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06) :733-744
[7]   Clinical utility gene card for: Hereditary thrombocythemia [J].
Hussein, Kais ;
Percy, Melanie ;
McMullin, Mary Frances ;
Schwarz, Jiri ;
Schnittger, Susanne ;
Porret, Naomi ;
Maria Martinez-Aviles, Luz ;
Bellosillo Paricio, Beatriz ;
Giraudier, Stephane ;
Skoda, Radek ;
Lippert, Eric ;
Hermouet, Sylvie ;
Cario, Holger .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2014, 22 (02) :293-293
[8]   Inherited predisposition to myeloproliferative neoplasms [J].
Jones, Amy V. ;
Cross, Nicholas C. P. .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (04) :237-253
[9]   The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms [J].
Jones, Amy V. ;
Campbell, Peter J. ;
Beer, Philip A. ;
Schnittger, Susanne ;
Vannucchi, Alessandro M. ;
Zoi, Katerina ;
Percy, Melanie J. ;
McMullin, Mary Frances ;
Scott, Linda M. ;
Tapper, William ;
Silver, Richard T. ;
Oscier, David ;
Harrison, Claire N. ;
Grallert, Harald ;
Kisialiou, Aliaksei ;
Strike, Paul ;
Chase, Andrew J. ;
Green, Anthony R. ;
Cross, Nicholas C. P. .
BLOOD, 2010, 115 (22) :4517-4523
[10]   JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms [J].
Jones, Amy V. ;
Chase, Andrew ;
Silver, Richard T. ;
Oscier, David ;
Zoi, Katerina ;
Wang, Y. Lynn ;
Cario, Holger ;
Pahl, Heike L. ;
Collins, Andrew ;
Reiter, Andreas ;
Grand, Francis ;
Cross, Nicholas C. P. .
NATURE GENETICS, 2009, 41 (04) :446-449